Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Mannkind Denied Again by FDA; Investors Should Consider Generex
Mannkind Denied Again by FDA; Investors Should Consider Generex
Mannkind Denied Again by FDA; Investors Should Consider Generex
Submitted by
admin
on April 13, 2011 - 7:55am
Source:
Seeking Alpha
News Tags:
inhaled insulin
MannKind
FDA
Generex
Afrezza
Headline:
Mannkind Denied Again by FDA; Investors Should Consider Generex
Do Not Allow Advertisers to Use My Personal information
